📊 Get daily AI-graded market briefings
Morning + evening · AI impact + sector exposure · Free
LAST 30 DAYS
3 articles
AVG GRADE
NEUTRAL
score: 0.17
SENTIMENT
NEUTRAL
TOTAL VIEWS
16
ARQT Stock Analysis & AI Grade: NEUTRAL
3 articles analyzed · Sentiment: NEUTRAL · AI-powered equity research
RECENT COVERAGE · 3 ARTICLES
Arcutis Biotherapeutics, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:ARQT) 2026-08-06
Arcutis Biotherapeutics (ARQT) released its 2026 Q2 earnings presentation on August 6, 2026. The disclosure consists primarily of a...
Arcutis President and CEO Todd Watanabe Sells 4,375 Shares for $114,275 as Q2 Results Demonstrate Profitability
Arcutis (ARQT) CEO Todd Watanabe executed a non-discretionary equity sale of 4,375 shares valued at $114,275, driven entirely by tax...
Arcutis to Report Second Quarter 2026 Financial Results and Host Conference Call on August 5, 2026
ARQT has scheduled its Q2 2026 earnings announcement for August 5, 2026, followed by a management conference call. This represents a...
E
ESEN Analytics
AI-powered equity research platform covering 5,000+ US equities. Our proprietary AI grading system (A+ to D scale) analyzes fundamentals, technicals, and news sentiment daily. Coverage data updated every 24 hours.
Learn about our methodology →
ⓘ AI-graded news coverage · Not investment advice